» Articles » PMID: 34647492

Gastrointestinal Microbiome and Gluten in Celiac Disease

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2021 Oct 14
PMID 34647492
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Coeliac disease (CD), also known as gluten sensitive enteropathy, is an autoimmune intestinal disease induced by gluten in genetically susceptible individuals. Gluten is a common ingredient in daily diet and is one of the main environmental factors to induce coeliac disease. Adhering to gluten free diet (GFD) is an effective method for treating CD. Microbiota plays an extremely important role in maintaining human health, and diet is the main factor to regulate the composition and function of gut microbiota. Recent studies have shown that gluten metabolism is closely related to gastrointestinal tract (GIT) microbiota. With the increasing prevalence of coeliac disease, there is a need for alternative treatments to GFD. In this review, biological medication of gluten, relationship between gluten and gut microflora, effect of GFD on GIT microflora, and effect of probiotics on CD were reviewed. By analysing the research progress on relationship between gluten and gastrointestinal microbiome in coeliac disease, this review tried to explore the prospective and potential mechanism of microecological agents in treating coeliac disease.

Citing Articles

The Role of Gluten in the Development of Autoimmune Thyroid Diseases: A Narrative Review.

Esfahani K, Asri N, Mahmoudi Ghehsareh M, Rezaei-Tavirani M, Jahani-Sherafat S, Rostami-Nejad M Int J Endocrinol Metab. 2025; 22(3):e153730.

PMID: 40065831 PMC: 11892518. DOI: 10.5812/ijem-153730.


Celiac Disease: Beyond Diet and Food Awareness.

Herrera-Quintana L, Navajas-Porras B, Vazquez-Lorente H, Hinojosa-Nogueira D, Corrales-Borrego F, Lopez-Garzon M Foods. 2025; 14(3).

PMID: 39941971 PMC: 11817883. DOI: 10.3390/foods14030377.


Assessment of salivary microbiota profile as a potential diagnostic tool for pediatric celiac disease.

Noruzpour A, Gholam-Mostafaei F, Azizmohammad Looha M, Dabiri H, Ahmadipour S, Rouhani P Sci Rep. 2024; 14(1):16712.

PMID: 39030381 PMC: 11271620. DOI: 10.1038/s41598-024-67677-4.


How the Microbiota May Affect Celiac Disease and What We Can Do.

Matera M, Guandalini S Nutrients. 2024; 16(12).

PMID: 38931237 PMC: 11206804. DOI: 10.3390/nu16121882.


Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota.

Annunziato A, Vacca M, Cristofori F, Dargenio V, Celano G, Francavilla R Nutrients. 2024; 16(11).

PMID: 38892582 PMC: 11174386. DOI: 10.3390/nu16111649.


References
1.
Lebwohl B, Sanders D, Green P . Coeliac disease. Lancet. 2017; 391(10115):70-81. DOI: 10.1016/S0140-6736(17)31796-8. View

2.
Reddel S, Putignani L, Del Chierico F . The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions. Nutrients. 2019; 11(2). PMC: 6413021. DOI: 10.3390/nu11020373. View

3.
Sommer F, Backhed F . The gut microbiota--masters of host development and physiology. Nat Rev Microbiol. 2013; 11(4):227-38. DOI: 10.1038/nrmicro2974. View

4.
Shang L, Deng D, Buskermolen J, Janus M, Krom B, Roffel S . Multi-species oral biofilm promotes reconstructed human gingiva epithelial barrier function. Sci Rep. 2018; 8(1):16061. PMC: 6207751. DOI: 10.1038/s41598-018-34390-y. View

5.
Caminero A, McCarville J, Galipeau H, Deraison C, Bernier S, Constante M . Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019; 10(1):1198. PMC: 6416356. DOI: 10.1038/s41467-019-09037-9. View